Clinical research depends on multi-site collaboration — yet the obligations protecting patient data make centralizing records legally, ethically, and scientifically untenable. Federated computing resolves this tension. Institutions share knowledge, not records.
Multi-site research has long assumed that meaningful collaboration requires data aggregation. In practice, centralized repositories create obligations that most institutions cannot honor — and risks that patients did not consent to bear.
"Every time we ask a site to transfer patient data to a central repository, we are asking them to go back to their IRB, reinterpret their consent forms, and accept liability they were never designed to carry."
Federated analyses derive their validity from the quality of data at each participating site. Poor source data does not produce uncertain results — it produces confidently wrong ones. Data quality standards are a prerequisite for federation, not a downstream concern.
Systematic missingness — when data is absent not at random — introduces bias that scales across a federated network. Each site must characterize its missingness patterns and document imputation strategies before contributing to any federated analysis.
Multi-site data routinely uses inconsistent variable coding, unit conventions, and clinical terminology. Harmonization to SNOMED CT, LOINC, MedDRA, and alignment to CDISC SDTM or OMOP CDM is required before data can be meaningfully federated.
Clinical data is inherently time-ordered. Timestamp errors, visit-date ambiguities, and event sequencing issues create serious confounding in longitudinal federated analyses. Temporal validation is a site-level requirement prior to federation.
Federated study results submitted to regulators must be traceable to auditable source data at each contributing site. Local data management practices must meet the same evidentiary standards expected of centralized trial databases.
Rather than moving data to a central analytical environment, the analysis protocol is distributed to each participating institution. Each site executes the protocol locally and returns only encrypted statistical contributions — never patient records.
Federated architecture — multi-site clinical research network
Mathematically calibrated noise is added to aggregate statistics before transmission, ensuring it is computationally infeasible to reconstruct individual patient records — or even individual site contributions — from the combined output, even under adversarial conditions.
Cryptographic protocols allow participating sites to jointly compute aggregate results without any party — including the coordinating institution — observing another site's individual statistical contributions. Particularly relevant for commercially sensitive or competitive research contexts.
Every federated analysis round is logged locally with cryptographic signatures. Each site retains a complete record of what analysis protocol was executed, what data elements were accessed, and what statistical outputs were transmitted — satisfying both regulatory and IRB audit requirements independently of the coordinating institution.
Participation in any federated study is opt-in at the site and protocol level. Data elements included in any analysis are automatically constrained to those covered by the relevant consent framework at each site. Sites may withdraw from any analysis round without affecting their participation in others.
By preserving institutional data governance while enabling multi-site statistical collaboration, federated computing opens research questions that centralized approaches cannot safely address.
Before a trial is initiated, federated queries across participating registries and EHR networks characterize the eligible patient population at each site — informing sample size estimates, site selection, and protocol parameters without any patient-level data transfer.
Federated safety monitoring aggregates adverse event signals across all participating sites in real time, producing network-level safety intelligence that no single site could observe alone — while each site's patient records remain entirely local and under local governance.
Where randomized placebo controls are infeasible, federated analyses of real-world EHR data construct synthetic comparator populations from multiple institutions — substantially increasing statistical validity compared to single-site historical controls, without pooling records.
Federated subgroup analyses identify differential response patterns across institutions, geographic regions, and patient populations — producing reproducible HTE findings with the statistical power that only network-scale data provides.
Federated analyses of post-approval EHR and registry data characterize how interventions perform across the full diversity of clinical practice — comorbidity profiles, prescribing patterns, and patient populations not represented in the original trial — without requiring any patient data to leave its source institution.
Regulatory frameworks for research data governance are tightening across all major jurisdictions. Federated computing is structurally aligned with the direction of travel — satisfying data minimization, provenance, and audit-readiness requirements without special accommodation.
Our team includes clinical data scientists and regulatory specialists who can evaluate federated computing for your specific protocol and institutional context.